FEMJA transplatation for limbal stem cell deficiency

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 May 2019: Trial registered, NCT03949881
  2. 13 Nov 2020: Trial started, NCT03949881

The trials

NCT03949881: Cultured Autologous Oral Mucosa Epithelial Sheet for the Treatment of Bilateral Limbal Stem Cell Deficiency

State
Under way
Phase
Phase 1 and Phase 2
People
40 planned
Started
13 Nov 2020
Primary completion
13 May 2031
Arms
FEMJA transplatation
Results
None posted
  1. 14 May 2019: Trial registered
  2. 13 Nov 2020: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.